These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16205015)

  • 1. [Recent progress in cyclic nucleotide phosphodiesterase research: isozymes, functions, and inhibitors].
    Kotera J; Sasaki T; Omori K
    Nihon Yakurigaku Zasshi; 2005 Aug; 126(2):121-7. PubMed ID: 16205015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclic nucleotides phosphodiesterases inhibitors].
    Hagiwara M; Hidaka H
    Nihon Rinsho; 1991 Sep; 49(9):1993-8. PubMed ID: 1660084
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.
    Torphy TJ
    Am J Respir Crit Care Med; 1998 Feb; 157(2):351-70. PubMed ID: 9476844
    [No Abstract]   [Full Text] [Related]  

  • 4. Ginsenosides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes.
    Sharma RK; Kalra J
    Biochemistry; 1993 May; 32(19):4975-8. PubMed ID: 8388250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular cyclic nucleotide phosphodiesterases and their role in regulating cardiovascular function.
    Pagani ED; Buchholz RA; Silver PJ
    Basic Res Cardiol; 1992; 87 Suppl 1():73-86. PubMed ID: 1379794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme.
    Kakkar R; Raju RV; Rajput AH; Sharma RK
    Brain Res; 1997 Feb; 749(2):290-4. PubMed ID: 9138729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta.
    Saeki T; Saito I
    Biochem Pharmacol; 1993 Sep; 46(5):833-9. PubMed ID: 8396936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase isozymes in rat mesangial cells.
    Ahn HS; Foster M; Arik L; Boykow G; Foster C
    Eur J Pharmacol; 1995 Mar; 289(1):49-57. PubMed ID: 7781711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation.
    Essayan DM
    Biochem Pharmacol; 1999 May; 57(9):965-73. PubMed ID: 10796066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
    Qiu Y; Kraft P; Lombardi E; Clancy J
    J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of rabbit ciliary process cyclic nucleotides to specific phosphodiesterase inhibitors.
    Okada K; Gregory DS
    Curr Eye Res; 2000 Oct; 21(4):774-81. PubMed ID: 11120567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary identification and role of phosphodiesterase isozymes in human basophils.
    Peachell PT; Undem BJ; Schleimer RP; MacGlashan DW; Lichtenstein LM; Cieslinski LB; Torphy TJ
    J Immunol; 1992 Apr; 148(8):2503-10. PubMed ID: 1373172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterases.
    Essayan DM
    J Allergy Clin Immunol; 2001 Nov; 108(5):671-80. PubMed ID: 11692087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents.
    Manganiello VC; Degerman E
    Thromb Haemost; 1999 Aug; 82(2):407-11. PubMed ID: 10605731
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclic nucleotides and phosphodiesterases and airway function.
    Barnes PJ
    Eur Respir J; 1995 Mar; 8(3):457-62. PubMed ID: 7789494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
    Seftel AD
    J Urol; 2005 Sep; 174(3):1043. PubMed ID: 16094045
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of isoenzymes of dog heart phosphodiesterase by blue, yellow and red triazine dyes.
    Clapham JC; Wilderspin AF
    Biochem Soc Trans; 1994 May; 22(2):216S. PubMed ID: 7958278
    [No Abstract]   [Full Text] [Related]  

  • 20. Design, synthesis and biological activity of beta-carboline-based type-5 phosphodiesterase inhibitors.
    Maw GN; Allerton CM; Gbekor E; Million WA
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1425-8. PubMed ID: 12668004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.